Metabotropic Glutamate Receptor Market Report: Trends, Forecast and Competitive Analysis to 2030

January 2024 | 150 pages | ID: ME3A8CA0A82EEN
Lucintel

Abstracts

Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.

Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.

Contents

1. EXECUTIVE SUMMARY


2. GLOBAL METABOTROPIC GLUTAMATE RECEPTOR MARKET : MARKET DYNAMICS

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Metabotropic Glutamate Receptor Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Metabotropic Glutamate Receptor Market by Product Type
  3.3.1: mGluR2
  3.3.2: mGluR4
  3.3.3: mGluR5
3.4: Global Metabotropic Glutamate Receptor Market by Application
  3.4.1: Attention Deficit Hyperactivity Disorder (ADHD)
  3.4.2: Alzheimer's Disease
  3.4.3: Chronic Obstructive Pulmonary Disease (COPD)

4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030

4.1: Global Metabotropic Glutamate Receptor Market by Region
4.2: North American Metabotropic Glutamate Receptor Market
  4.2.2: North American Metabotropic Glutamate Receptor Market by Application: Attention Deficit Hyperactivity Disorder, Alzheimer's Disease, and Chronic Obstructive Pulmonary Disease
4.3: European Metabotropic Glutamate Receptor Market
  4.3.1: European Metabotropic Glutamate Receptor Market by Product Type: mGluR2, mGluR4, and mGluR5
  4.3.2: European Metabotropic Glutamate Receptor Market by Application: Attention Deficit Hyperactivity Disorder, Alzheimer's Disease, and Chronic Obstructive Pulmonary Disease
4.4: APAC Metabotropic Glutamate Receptor Market
  4.4.1: APAC Metabotropic Glutamate Receptor Market by Product Type: mGluR2, mGluR4, and mGluR5
  4.4.2: APAC Metabotropic Glutamate Receptor Market by Application: Attention Deficit Hyperactivity Disorder, Alzheimer's Disease, and Chronic Obstructive Pulmonary Disease
4.5: ROW Metabotropic Glutamate Receptor Market
  4.5.1: ROW Metabotropic Glutamate Receptor Market by Product Type: mGluR2, mGluR4, and mGluR5
  4.5.2: ROW Metabotropic Glutamate Receptor Market by Application: Attention Deficit Hyperactivity Disorder, Alzheimer's Disease,and Chronic Obstructive Pulmonary Disease

5. COMPETITOR ANALYSIS

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS

6.1: Growth Opportunity Analysis
  6.1.1: Growth Opportunities for the Global Metabotropic Glutamate Receptor Market by Product Type
  6.1.2: Growth Opportunities for the Global Metabotropic Glutamate Receptor Market by Application
  6.1.3: Growth Opportunities for the Global Metabotropic Glutamate Receptor Market by Region
6.2: Emerging Trends in the Global Metabotropic Glutamate Receptor Market
6.3: Strategic Analysis
  6.3.1: New Product Development
  6.3.2: Capacity Expansion of the Global Metabotropic Glutamate Receptor Market
  6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Metabotropic Glutamate Receptor Market
  6.3.4: Certification and Licensing

7. COMPANY PROFILES OF LEADING PLAYERS

7.1: Eli Lilly and Company
7.2: Novartis International
7.3: Prexton Therapeutics
7.4: Addex Therapeutics
7.5: Taisho Pharmaceutical Holding
7.6: Astrazeneca
7.7: Domain Therapeutic
7.8: Abcam
7.9: Johnson & Johnson
7.10: Medgenic